Search Within

Sujata Patil

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (70)
  2. Journal Article (55)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Biostatistics Service (127)
  2. Department of Medicine (127)
  3. Epidemiology and Biostatistics (127)
  4. Population Sciences Research Program (127)
  5. Solid Tumor Oncology Division (126)
  6. Survivorship Research (106)

More Groups

People
  1. Clifford Hudis (44)
  2. Shari Goldfarb (34)
  3. Mark Robson (32)
  4. Chau Dang (30)
  5. Larry Norton (29)
  6. Shanu Modi (25)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (10)
  4. 2020 (17)
  5. 2019 (14)
  6. 2018 (10)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Cancer Research (18)
  3. Breast Cancer Research and Treatment (9)
  4. Cancer (7)
  5. The Oncologist (5)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (45)
  2. American Association for Cancer Research (22)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Wiley Blackwell (8)
  6. Oxford University Press (5)

More Publishers

Results (127)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis
    Meeting Abstract

    Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Work status after treatment for breast cancer: A controlled, prospective, longitudinal study of an ethnically diverse cohort
    Meeting Abstract

    Blinder, V. S.; Patil, S.; Eberle, C. E.; Jung, G.; Kampel, L. J.; Hwang, C.; Bao, T.; Robson, M. E.; Malik, M.; Gany, F.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The CHANCE study: A prospective, longitudinal study of chemotherapy and hormonal therapy induced hair changes and alopecia, skin aging and nail changes in women with non-metastatic breast cancer
    Meeting Abstract

    Lacouture, M. E.; Freites-Martinez, A.; Patil, S.; Samuels, A.; Shapiro, J.; Ciccolini, K.; Kukoyi, O.; Goldfarb, S. B.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
    Meeting Abstract

    Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Racial disparities in chemotherapy administration for early-stage breast cancer: A systematic review and meta-analysis
    Journal Article

    Green, A. K.; Aviki, E. M.; Matsoukas, K.; Patil, S.; Korenstein, D.; Blinder, V.
    Breast Cancer Research and Treatment (2018)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma
    Journal Article

    Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
    Kidney Cancer (2017)

    Fulltext@MSK | Save